Expert insights on technology and business growth
Declined: a young company's first SR&ED claim was under $100k, and the next year's claim hadn't been prepared. Why that was too small to lend against.
Approved: a biotech company's SR&ED claim was under CRA review when it came to us. Why we still lent, and why the advance sat lower than usual.
An aggressive, in-house SR&ED claim was declined because we couldn't rely on it to survive a CRA review. Why lenders won't dig, and what to do instead.
A strong SR&ED claim was declined because the bank had the company in special loans. Why that usually ends it, and what to do instead.
Why SR&ED lenders keep leaving the market, what to do if yours stopped funding, and how to tell if the next one will still be there.
Canadian tech companies can borrow against SR&ED credit earned this year, before filing. Grow Financial advances 75% to 100% of expected refundable credits (minimum $100,000), drawing quarterly from $25,000. Loans are based on accrued SR&ED, repaid from the CRA refund, and best used when you genuinely need cash, not as an equity substitute.
SR&ED refunds arrive long after the salaries that earned them, and cutting staff to close the gap shrinks next year's claim. Garron Helman explains the real options, how a lender tells a bridge from a lifeline, and how a growing 8-person software company made payroll with one day to spare.